title: Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
authors.affiliation: Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA. dcdesjarla@aol.com
authors.forename: D C
authors.initials: DC
authors.lastname: Des Jarlais
authors.forename: D G
authors.initials: DG
authors.lastname: Fisher
authors.forename: J C
authors.initials: JC
authors.lastname: Newman
authors.forename: B N
authors.initials: BN
authors.lastname: Trubatch
authors.forename: M
authors.initials: M
authors.lastname: Yancovitz
authors.forename: D
authors.initials: D
authors.lastname: Paone
authors.forename: D
authors.initials: D
authors.lastname: Perlman
mesh_terms: D000413:Alaska; D003151:Community Health Centers; D006509:Hepatitis B / Q000209:etiology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D008137:Longitudinal Studies; D018671:Needle-Exchange Programs; D012017:Referral and Consultation; D015819:Substance Abuse, Intravenous / Q000150:complications*
chemical_list: D017325:Hepatitis B Vaccines